Central venous lines in haemophilia

Haemophilia

Volumn 9, Issue SUPPL. 1, 2003, Pages 88-93

  Ljung, Rolf ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Catheter; Factor IX; Factor VIII; Haemophilia A; Haemophilia B

Indexed keywords

ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE; EMLA; UROKINASE;

ARTICLE; ASEPSIS; BLEEDING TENDENCY; CATHETER INFECTION; CENTRAL VENOUS CATHETER; EXPERIENCE; FREQUENCY ANALYSIS; HEMOPHILIA; HUMAN; INFECTION RISK; MEDICAL DECISION MAKING; MEDICAL RECORD; PATIENT EDUCATION; PATIENT MONITORING; PHLEBOGRAPHY; PRIORITY JOURNAL; SKIN INJURY; SOCIAL ASPECT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; THROMBOPHLEBITIS; THROMBOSIS;

EID: 0038779219     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.9.s1.7.x     Document Type: Article

References (25)

1. Ljung RC. Can haemophilic arthropathy be prevented? Br J Haematol 1998; 101: 215-9.
2. McWhirter WR, Gray L. Indwelling intravenous catheter in a young haemophiliac. Lancet 1988; 2: 99-100.
3. Ljung R, Petrini P, Lindgren AK, Berntorp E. Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia. Acta Paediatr 1992; 81: 918-20.
4. Liesner RJ, Vora AJ, Hann IM, Lilleymann JS. Use of central venous catheters in children with severe congenital coagulopathy. Br J Haematol 1995; 91: 203-7.
5. Warrier I, Baird-Cox K, Lusher J. Use of central venous catheters in children with haemophilia: one haemophilia treatment centre experience. Haemophilia 1997; 3: 194-8.
6. Blanchette VS, al Musa A, Stain AM, Filler RM, Ingram J. Central venous access catheters in children with haemophilia. Blood Coagul Fibrinolysis 1996; 7 (Suppl. 1): S39-44.
7. Blanchette VS, Al Musa A, Stain AM, Ingram J, Fille RM. Central venous access devices in children with hemophilia: an update. Blood Coagul Fibrinolysis 1997; 8 (Suppl. 1): S11-4.
8. Perkins JL, Johnson VA, Osip JM et al. The use of implantable venous access devices (IVADs) in children with hemophilia. J Pediatr Hematol Oncol 1997; 19: 339-44.
9. Ljung R, van den Berg M, Petrini P et al. Port-A-Cath usage in children with haemophilia: experience of 53 cases. Acta Paediatr 1998; 87: 1051-4.
10. Miller K, Buchanan GR, Zappa S et al. Implantable venous access devices in children with hemophilia: a report of low infection rates. J Pediatr 1998; 132: 934-8.
11. McMahon C, Smith J, Khair K, Liesner R, Hann I, Smith O. Central venous access devices in children with congenital coagulation disorders; complications and long-term outcome. Br J Haematol 2000; 110: 461-8.
12. Mumtaz H, Williams V, Hauer-Jensen M et al. Central venous catheter placement in patients with disorders of haemostasis. Am J Surg 2001; 180: 503-6.
13. Santagostino E, Gringeri A, Muca Perja M, Mannucci PM. A prospective clinical trial of implantable central venous access in children with haemophilia. Br J Haematol 1998; 102: 1224-8.
14. Ingram J, Wietzman S, Greenberg ML. Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports. J Pediatr Hematol Oncol 1991; 13: 130-6.
15. Berntorp E, Frick K, Mätzsch T, Carlsson M, Lethagen S. The Percuseal device - a new option for effective continuous prophylaxis? Haemophilia 1998; 4 (3): 184.
16. Van den Berg HM, Fischer K, Roosendaal G, Mauser Bunschoten EP. The use of the Port-A-Cath in children with haemophilia - a review. Haemophilia 1998; 4: 418-20.
17. Collins PW, Khair KS, Liesner R, Hann IM. Complications experienced with central venous catheters in children with congenital bleeding disorders. Br J Haematol 1997; 99: 206-8.
18. Lim SH, Smith MP, Machin SJ, Goldstone AH. A prospective randomised study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for hematological malignancies. Eur J Haematol Supplement 1993; 54: 10-3.
19. Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 1990; 15: 95-102.
20. Journeycake JM, Quinn CT, Miller KL, Zajac JL, Buchanan GR. Catheter-related deep venous thrombosis in children with hemophilia. Blood 2001; 98: 1727-31.
21. Medeiros D, Miller KL, Rollins NK, Buchanan GR. Contrast venography in young haemophiliacs with implantable central venous access devices. Haemophilia 1998; 4: 10-5.
22. Vidler V, Richards M, Vora A. Central venous catheter-associated thrombosis in severe haemophilia. Br J Haematol 1999; 104: 461-4.
23. Hothi D, Kelsall W, Baglin T, Williams D. Bacterial endocarditis in a child with haemophilia B: risks of central venous catheters. Haemophilia 2001; 7: 507-510.
24. Ettingshausen C, Kurnik K, Schobess R et al. Catheter related thrombosis in children with haemophilia A: evidence of a multifactorial disease. Blood 2002; 99: 449-500.
25. Ljung R, Aronis-Vournas S, Kurnik-Auberger K et al. Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries. Haemophilia 2000; 6: 619-24.